Cargando…
Mannose 6‐phosphonate labelling: A key for processing the therapeutic enzyme in Pompe disease
In the search of a better enzyme therapy in Pompe disease, the conjugation of mannose 6‐phosphonates to the recombinant enzyme appeared as an enhancer of its efficacy. Here, we demonstrated that the increased efficacy of the conjugated enzyme is partly due to a higher intracellular maturation becaus...
Autores principales: | Godefroy, Anastasia, Daurat, Morgane, Da Silva, Afitz, Basile, Ilaria, El Cheikh, Khaled, Caillaud, Catherine, Sacconi, Sabrina, Schoser, Benedikt, Charbonné, Henry‐Vincent, Gary‐Bobo, Magali, Morère, Alain, Garcia, Marcel, Maynadier, Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714136/ https://www.ncbi.nlm.nih.gov/pubmed/31293082 http://dx.doi.org/10.1111/jcmm.14516 |
Ejemplares similares
-
Efficient Photodynamic Therapy of Prostate Cancer Cells through an Improved Targeting of the Cation-Independent Mannose 6-Phosphate Receptor
por: Bouffard, Elise, et al.
Publicado: (2019) -
Stealth Biocompatible Si-Based Nanoparticles for Biomedical Applications
por: Liu, Wei, et al.
Publicado: (2017) -
Biosafety of Mesoporous Silica Nanoparticles
por: Rascol, Estelle, et al.
Publicado: (2018) -
Biological Fate of Fe(3)O(4) Core-Shell Mesoporous Silica Nanoparticles Depending on Particle Surface Chemistry
por: Rascol, Estelle, et al.
Publicado: (2017) -
Alglucosidase alfa: 5 years of experience in late-onset Pompe disease
por: Schoser, Benedikt
Publicado: (2013)